Free Trial
→ Is President Trump Lying To You With This? (From Colonial Metals) (Ad) Buy BTAFF Stock  Free BTAFF Stock Alerts

British American Tobacco (BTAFF) Financials

British American Tobacco logo
$45.54 +1.70 (+3.89%)
As of 05/23/2025 02:19 PM Eastern
Compare
Annual Income Statements for British American Tobacco

Annual Income Statements for British American Tobacco

This table shows British American Tobacco's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders		 4,124 -17,854 8,485 9,648 9,188 10,063 29,028 51,100 6,206 7,006
Consolidated Net Income / (Loss)		 3,983 -18,081 8,268 9,415 8,965 0.00 7,685 50,869 5,971 6,664
Net Income / (Loss) Continuing Operations		 3,983 -18,081 8,268 9,415 8,965 10,255 29,254 50,869 5,971 6,664
Total Pre-Tax Income 		4,430 -21,741 11,261 12,370 11,843 10,484 31,982 39,888 7,705 8,629
Total Operating Income		 3,426 -20,071 12,709 13,816 13,605 11,947 29,685 8,662 5,744 6,716
Total Gross Profit		 26,834 28,853 27,899 28,758 29,551 15,432 31,116 19,630 12,828 14,842
Total Revenue		 32,388 34,767 33,399 34,673 35,203 36,412 49,526 26,429 17,434 19,312
Operating Revenue		 32,388 34,767 33,399 34,673 35,203 36,412 49,526 26,429 17,434 19,312
Total Cost of Revenue		 5,554 5,914 5,500 5,916 5,651 20,980 18,410 6,799 4,606 4,470
Operating Cost of Revenue		 5,554 5,914 5,500 5,916 5,651 20,980 18,410 6,799 4,606 4,470
Total Operating Expenses		 23,408 48,924 15,190 14,942 15,946 2,663 1,431 10,968 7,085 8,126
Selling, General & Admin Expense		 3,545 3,395 3,589 3,668 3,748 - - 3,619 2,806 3,005
Depreciation Expense		 3,883 36,463 1,576 1,453 1,980 - 1,322 1,219 749 631
Amortization Expense		 13 11 6.04 4.05 4.10 - - 0.00 0.00 -
Other Operating Expenses / (Income)		 15,968 9,055 10,019 9,817 10,214 660 108 6,130 3,530 4,490
Total Other Income / (Expense), net		 1,004 -1,669 -1,448 -1,446 -1,762 220 2,297 31,226 1,962 1,913
Interest Expense		 1,375 2,415 1,982 2,006 2,383 - - 1,478 786 -91
Other Income / (Expense), net		 2,379 745 534 560 621 216 2,297 32,704 2,748 1,822
Income Tax Expense		 447 -3,660 2,993 2,955 2,879 2,734 2,728 -10,981 1,735 1,964
Net Income / (Loss) Attributable to Noncontrolling Interest		 -141 -227 -217 -234 -224 192 227 -231 -236 -342
Weighted Average Basic Shares Outstanding		 1.71 -8.24 3.54 2.97 2.80 2.46B 2.46B 24.77 2.50 230.90
Diluted Earnings per Share		 $1.70 ($8.24) $3.53 $2.96 $2.79 $2.49 $2.63 $24.69 $2.49 $230.30
Weighted Average Diluted Shares Outstanding		 2.35B 2.46B 2.46B 2.46B 2.46B 2.46B 2.46B 2.46B - -
Weighted Average Basic & Diluted Shares Outstanding		 2.35B 2.46B 2.46B 2.46B 2.46B 2.46B 2.46B 2.46B - -

Quarterly Income Statements for British American Tobacco

No quarterly income statements for British American Tobacco are available.

Annual Cash Flow Statements for British American Tobacco

This table details how cash moves in and out of British American Tobacco's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents		 -2,583 29,354 -4,685 -806 1,551 388 629 3,692 -3,745 -3,953
Net Cash From Operating Activities		 3,659 35,781 1,370 13,118 8,189 15,416 2,051 7,223 -83 50
Net Cash From Continuing Operating Activities		 3,659 35,781 1,370 13,167 8,189 15,416 2,051 7,045 -83 50
Net Income / (Loss) Continuing Operations		 3,983 -18,081 8,268 9,415 8,965 0.00 0.00 8,266 0.00 0.00
Consolidated Net Income / (Loss)		 3,983 -18,081 8,268 9,415 8,965 0.00 - 8,266 - -
Depreciation Expense		 3,883 36,463 1,576 1,453 1,980 - - 1,219 749 631
Non-Cash Adjustments To Reconcile Net Income		 -4,207 17,399 -8,474 5,458 -2,756 15,416 2,051 116 -832 -581
Net Cash From Investing Activities		 285 14 -118 -1,539 -157 633 690 -25,051 7.40 80
Net Cash From Continuing Investing Activities		 285 14 -118 -1,359 -157 633 690 -24,947 7.40 80
Purchase of Investments		 -270 -571 -310 -498 -468 253 408 -230 -134 -146
Sale of Property, Plant & Equipment		 182 69 37 42 60 45 48 128 115 159
Sale and/or Maturity of Investments		 374 516 155 235 251 449 213 328 27 66
Net Cash From Financing Activities		 -6,527 -6,442 -5,936 -11,811 -6,480 13,101 5,538 19,938 -3,669 -4,082
Net Cash From Continuing Financing Activities		 -6,527 -6,442 -5,936 -11,764 -6,480 13,101 5,538 20,774 -3,669 -4,082
Payment of Dividends		 -6,527 -6,442 -5,936 -6,823 -6,480 - 5,538 -4,906 -3,591 -4,082
Cash Interest Paid		 2,132 2,143 1,906 - - 2,121 - - - -
Cash Interest Received		 234 185 103 - 66 - 66 - 76 94

Quarterly Cash Flow Statements for British American Tobacco

No quarterly cash flow statements for British American Tobacco are available.

Annual Balance Sheets for British American Tobacco

This table presents British American Tobacco's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Total Assets		 148,873 151,280 185,438 185,443 188,045 186,843 186,437 190,548 49,074
Total Current Assets		 17,898 18,077 18,609 17,289 18,590 17,589 16,122 19,630 15,249
Cash & Equivalents		 6,632 5,937 4,162 3,792 4,287 3,347 3,315 4,446 2,719
Short-Term Investments		 825 916 845 683 587 163 - 145 -
Accounts Receivable		 4,866 5,023 5,565 5,617 5,082 5,752 5,444 6,496 5,531
Inventories, net		 5,780 6,292 6,849 7,127 8,196 8,075 7,681 7,922 7,148
Plant, Property, & Equipment, net		 5,483 5,840 0.00 6,687 6,910 7,312 6,581 6,595 4,517
Plant, Property & Equipment, gross		 5,483 5,840 - 6,687 6,910 7,312 6,581 6,595 4,517
Total Noncurrent Assets		 125,288 127,271 162,139 161,537 162,514 161,843 163,140 164,324 17,357
Long-Term Investments		 2,381 2,510 2,440 2,630 2,453 2,465 2,213 2,130 -
Intangible Assets		 118,043 121,775 155,884 156,094 157,525 157,402 157,990 159,115 14,951
Noncurrent Deferred & Refundable Income Taxes		 3,306 1,380 1,004 983 729 562 533 450 623
Employee Benefit Assets		 1,173 1,218 1,208 1,239 - - 1,461 1,517 561
Other Noncurrent Operating Assets		 371 370 678 574 1,807 1,410 936 1,105 1,198
Other Noncurrent Nonoperating Assets		 14 18 926 18 - 3.98 6.37 6.75 23
Total Liabilities & Shareholders' Equity		 148,873 151,280 185,438 185,443 188,045 186,843 186,437 355,006 49,074
Total Liabilities		 88,384 85,973 95,521 96,726 100,881 102,015 102,752 144,106 38,702
Total Current Liabilities		 15,451 15,266 16,148 15,865 21,138 15,404 16,632 50,688 11,846
Accounts Payable		 12,815 13,499 13,759 14,255 13,238 14,259 14,888 13,463 10,333
Current Deferred & Payable Income Tax Liabilities		 2,105 1,264 1,267 1,187 - 905 1,087 973 688
Other Current Liabilities		 531 503 1,122 424 1,196 240 657 36,252 824
Total Noncurrent Liabilities		 72,934 70,707 79,372 80,861 80,928 86,611 86,120 93,418 26,856
Long-Term Debt		 48,375 52,775 54,134 55,813 54,529 60,114 60,526 66,802 24,054
Noncurrent Deferred & Payable Income Tax Liabilities		 14,623 15,536 22,255 22,224 22,280 22,593 22,646 23,139 804
Noncurrent Employee Benefit Liabilities		 1,027 1,123 1,146 1,673 2,081 2,503 2,121 2,460 1,019
Other Noncurrent Operating Liabilities		 8,909 1,273 1,837 1,152 2,038 1,402 827 1,017 978
Total Equity & Noncontrolling Interests		 60,489 65,307 89,756 88,717 58,639 85,017 83,685 210,900 10,372
Total Preferred & Common Equity		 60,048 64,838 89,343 88,312 85,593 84,675 83,374 210,600 10,095
Total Common Equity		 60,048 64,838 89,343 88,312 58,254 84,675 83,374 210,600 10,095
Common Stock		 732 782 742 829 839 814 782 829 626
Retained Earnings		 27,058 31,260 53,237 59,686 57,416 53,313 49,121 49,895 4,110
Other Equity Adjustments		 32,258 32,795 35,365 27,797 - 30,548 33,471 159,875 5,360
Noncontrolling Interest		 441 469 413 405 385 342 311 300 276

Quarterly Balance Sheets for British American Tobacco

This table presents British American Tobacco's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q4 2023 Q4 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets		 148,873 151,280 185,438
Total Current Assets		 17,898 18,077 18,609
Cash & Equivalents		 6,632 5,937 4,162
Short-Term Investments		 825 916 845
Accounts Receivable		 4,866 5,023 5,565
Inventories, net		 5,780 6,292 6,849
Plant, Property, & Equipment, net		 5,483 5,840 0.00
Plant, Property & Equipment, gross		 5,483 5,840 -
Total Noncurrent Assets		 125,288 127,271 162,139
Long-Term Investments		 2,381 2,510 2,440
Intangible Assets		 118,043 121,775 155,884
Noncurrent Deferred & Refundable Income Taxes		 3,306 1,380 1,004
Employee Benefit Assets		 1,173 1,218 1,208
Other Noncurrent Operating Assets		 371 370 678
Other Noncurrent Nonoperating Assets		 14 18 926
Total Liabilities & Shareholders' Equity		 148,873 151,280 185,438
Total Liabilities		 88,384 85,973 95,521
Total Current Liabilities		 15,451 15,266 16,148
Accounts Payable		 12,815 13,499 13,759
Current Deferred & Payable Income Tax Liabilities		 2,105 1,264 1,267
Other Current Liabilities		 531 503 1,122
Total Noncurrent Liabilities		 72,934 70,707 79,372
Long-Term Debt		 48,375 52,775 54,134
Noncurrent Deferred & Payable Income Tax Liabilities		 14,623 15,536 22,255
Noncurrent Employee Benefit Liabilities		 1,027 1,123 1,146
Other Noncurrent Operating Liabilities		 8,909 1,273 1,837
Total Equity & Noncontrolling Interests		 60,489 65,307 89,756
Total Preferred & Common Equity		 60,048 64,838 89,343
Total Common Equity		 60,048 64,838 89,343
Common Stock		 732 782 742
Retained Earnings		 27,058 31,260 53,237
Other Equity Adjustments		 32,258 32,795 35,365
Noncontrolling Interest		 441 469 413

Annual Metrics And Ratios for British American Tobacco

This table displays calculated financial ratios and metrics derived from British American Tobacco's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -6.84% 4.10% -3.68% -1.50% -3.32% -26.48% 87.39% 51.59% -9.72% 0.00%
EBITDA Growth		 -43.47% 15.64% -6.38% -2.33% 33.25% -63.48% -21.79% 360.85% 0.79% 0.00%
EBIT Growth		 130.04% -245.94% -7.89% 1.05% 16.97% -61.97% -22.68% 387.15% -0.54% 0.00%
NOPAT Growth		 121.92% -250.57% -11.26% 2.11% 16.60% -67.47% 145.81% 148.21% -14.20% 0.00%
Net Income Growth		 122.03% -318.69% -12.18% 5.02% 0.00% -100.00% -84.89% 751.99% -10.41% 0.00%
EPS Growth		 120.67% -333.73% 19.26% 5.99% 12.01% -5.40% -85.60% 890.73% -10.41% 0.00%
Operating Cash Flow Growth		 -89.77% 2,512.65% -89.56% 60.19% -46.88% 651.59% -71.60% 8,837.62% -264.98% 0.00%
Free Cash Flow Firm Growth		 81.14% -58.38% 34.09% 32.31% 12.87% 278.82% 93.74% -389.86% 0.00% 0.00%
Invested Capital Growth		 -8.91% -16.26% -5.54% -1.52% 0.54% 0.27% 29.93% 435.77% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 82.85% 82.99% 83.53% 82.94% 83.95% 42.38% 62.83% 74.27% 73.58% 76.85%
EBITDA Margin		 29.91% 49.29% 44.37% 45.65% 46.04% 33.40% 67.25% 161.13% 53.00% 47.47%
Operating Margin		 10.58% -57.73% 38.05% 39.85% 38.65% 32.81% 59.94% 32.77% 32.94% 34.78%
EBIT Margin		 17.92% -55.59% 39.65% 41.46% 40.41% 33.40% 64.58% 156.52% 48.70% 44.21%
Profit (Net Income) Margin		 12.30% -52.01% 24.76% 27.15% 25.47% 0.00% 15.52% 192.48% 34.25% 34.51%
Tax Burden Percent		 89.91% 83.17% 73.42% 76.11% 75.69% 0.00% 24.03% 127.53% 77.49% 77.23%
Interest Burden Percent		 76.32% 112.50% 85.03% 86.05% 83.25% 86.20% 100.00% 96.43% 90.74% 101.07%
Effective Tax Rate		 10.09% 0.00% 26.58% 23.89% 24.31% 26.07% 8.53% -27.53% 22.51% 22.77%
Return on Invested Capital (ROIC)		 2.97% -11.78% 6.98% 7.59% 7.40% 6.37% 22.17% 17.48% 44.77% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.17% -21.44% 4.59% 5.90% 5.42% -9.91% 100.57% -66.47% 76.74% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 3.37% -11.54% 2.28% 5.18% 5.08% -6.37% -16.96% 28.50% 70.36% 0.00%
Return on Equity (ROE)		 6.33% -23.32% 9.27% 12.78% 12.48% 0.00% 5.22% 45.98% 115.13% 0.00%
Cash Return on Invested Capital (CROIC)		 12.30% 5.91% 12.68% 9.12% 6.86% 6.10% -3.86% -119.60% -155.23% 0.00%
Operating Return on Assets (OROA)		 3.87% -11.48% 7.14% 7.70% 7.59% 6.52% 16.97% 34.53% 17.30% 0.00%
Return on Assets (ROA)		 2.65% -10.74% 4.46% 5.04% 4.78% 0.00% 4.08% 42.46% 12.17% 0.00%
Return on Common Equity (ROCE)		 6.29% -23.19% 9.22% 12.71% 12.42% 0.00% 5.21% 45.86% 112.06% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 6.63% -27.89% 9.25% 10.66% 10.47% 0.00% 9.22% 24.15% 59.14% 0.00%
Net Operating Profit after Tax (NOPAT)		 3,080 -14,050 9,331 10,515 10,298 8,832 27,153 11,047 4,450 5,187
NOPAT Margin		 9.51% -40.41% 27.94% 30.33% 29.25% 24.26% 54.83% 41.80% 25.53% 26.86%
Net Nonoperating Expense Percent (NNEP)		 -2.20% 9.66% 2.40% 1.70% 1.98% 16.28% -78.39% 83.95% -31.97% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 2.83% -11.90% 6.48% - - - - - - -
Cost of Revenue to Revenue		 17.15% 17.01% 16.47% 17.06% 16.05% 57.62% 37.17% 25.73% 26.42% 23.15%
SG&A Expenses to Revenue		 10.94% 9.76% 10.75% 10.58% 10.65% 0.00% 0.00% 13.69% 16.09% 15.56%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 72.27% 140.72% 45.48% 43.09% 45.30% 7.31% 2.89% 41.50% 40.64% 42.08%
Earnings before Interest and Taxes (EBIT)		 5,805 -19,326 13,242 14,376 14,227 12,163 31,982 41,366 8,491 8,537
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 9,687 17,137 14,818 15,829 16,207 12,163 33,304 42,584 9,240 9,168
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.49 0.99 0.90 0.89 1.25 0.90 0.64 0.49 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.02 0.00 0.00
Price to Revenue (P/Rev)		 2.75 1.85 2.40 2.27 2.07 2.10 1.08 3.93 0.00 0.00
Price to Earnings (P/E)		 21.63 0.00 9.45 8.16 7.94 7.61 1.85 2.03 0.00 0.00
Dividend Yield		 0.00% 11.10% 8.09% 9.19% 11.43% 8.29% 11.63% 6.84% 6.26% 6.92%
Earnings Yield		 4.62% 0.00% 10.59% 12.26% 12.59% 13.14% 54.04% 49.22% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.29 0.99 0.98 0.93 0.90 0.94 0.79 1.54 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 3.96 3.11 3.81 3.69 3.58 3.60 2.20 6.21 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 13.23 6.31 8.59 8.07 7.78 10.77 3.27 3.86 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 22.09 0.00 9.61 8.89 8.86 10.77 3.41 3.97 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 41.62 0.00 13.64 12.16 12.24 14.84 4.02 14.87 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 35.04 3.02 92.92 9.74 15.40 8.50 53.15 22.73 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 10.04 15.34 7.51 10.12 13.21 15.49 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.80 0.81 0.60 0.63 1.02 0.71 0.72 0.32 2.32 0.00
Long-Term Debt to Equity		 0.80 0.81 0.60 0.63 0.93 0.71 0.72 0.32 2.32 0.00
Financial Leverage		 0.65 0.54 0.50 0.88 0.94 0.64 -0.17 -0.43 0.92 0.00
Leverage Ratio		 2.39 2.17 2.08 2.53 2.61 2.21 1.28 1.08 4.73 0.00
Compound Leverage Factor		 1.82 2.44 1.77 2.18 2.17 1.91 1.28 1.04 4.29 0.00
Debt to Total Capital		 44.44% 44.69% 37.62% 38.62% 50.59% 41.42% 41.97% 24.06% 69.87% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 4.65% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 44.44% 44.69% 37.62% 38.62% 45.94% 41.42% 41.97% 24.06% 69.87% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.40% 0.40% 0.29% 0.28% 0.32% 0.24% 0.22% 0.11% 0.80% 0.00%
Common Equity to Total Capital		 55.16% 54.91% 62.09% 61.10% 49.08% 58.34% 57.81% 75.84% 29.33% 0.00%
Debt to EBITDA		 4.99 3.08 3.65 3.53 3.71 4.94 1.82 1.57 2.60 0.00
Net Debt to EBITDA		 3.98 2.53 3.15 3.08 3.25 4.45 1.65 1.41 2.31 0.00
Long-Term Debt to EBITDA		 4.99 3.08 3.65 3.53 3.36 4.94 1.82 1.57 2.60 0.00
Debt to NOPAT		 15.71 -3.76 5.80 5.31 5.83 6.81 2.23 6.05 5.40 0.00
Net Debt to NOPAT		 12.51 -3.09 5.00 4.63 5.12 6.13 2.03 5.44 4.79 0.00
Long-Term Debt to NOPAT		 15.71 -3.76 5.80 5.31 5.30 6.81 2.23 6.05 5.40 0.00
Altman Z-Score		 1.23 0.57 1.34 1.39 1.28 1.27 1.51 1.46 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.72% 0.57% 0.46% 0.54% 0.51% 0.39% 0.21% 0.26% 2.66% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 1.16 1.18 1.15 1.09 0.88 1.14 0.97 0.39 1.29 0.00
Quick Ratio		 0.80 0.78 0.65 0.64 0.47 0.60 0.53 0.22 0.70 0.00
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 12,769 7,050 16,938 12,632 9,547 8,459 -4,730 -75,589 -15,431 0.00
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 1,360.92% 0.00% 0.00% 0.00% 605.55% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 9.29 2.92 8.55 6.30 4.01 0.00 0.00 -51.15 -19.63 0.00
Operating Cash Flow to Interest Expense		 2.66 14.82 0.69 6.54 3.44 0.00 0.00 4.89 -0.11 0.00
Operating Cash Flow Less CapEx to Interest Expense		 2.79 14.85 0.71 6.06 3.46 0.00 0.00 4.08 0.04 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.22 0.21 0.18 0.19 0.19 0.20 0.26 0.22 0.36 0.00
Accounts Receivable Turnover		 6.55 6.57 5.97 6.48 6.50 6.50 8.30 4.39 3.15 0.00
Inventory Turnover		 0.92 0.90 0.79 0.77 0.69 2.66 2.36 0.90 0.64 0.00
Fixed Asset Turnover		 5.72 0.00 0.00 5.10 4.95 5.24 7.52 4.76 3.86 0.00
Accounts Payable Turnover		 0.42 0.43 0.39 0.43 0.41 1.44 1.30 0.57 0.45 0.00
Days Sales Outstanding (DSO)		 55.72 55.58 61.10 56.31 56.17 56.11 44.00 83.06 115.80 0.00
Days Inventory Outstanding (DIO)		 396.66 405.53 463.74 472.69 525.44 137.06 154.67 404.49 566.42 0.00
Days Payable Outstanding (DPO)		 864.60 841.15 929.58 848.15 887.97 253.54 281.04 638.75 818.88 0.00
Cash Conversion Cycle (CCC)		 -412.22 -380.04 -404.73 -319.14 -306.37 -60.37 -82.37 -151.20 -136.66 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 99,011 108,700 129,800 137,407 139,524 138,773 138,400 106,516 19,881 0.00
Invested Capital Turnover		 0.31 0.29 0.25 0.25 0.25 0.26 0.40 0.42 1.75 0.00
Increase / (Decrease) in Invested Capital		 -9,689 -21,100 -7,607 -2,117 751 373 31,884 86,635 19,881 0.00
Enterprise Value (EV)		 128,201 108,139 127,260 127,816 126,094 131,043 109,024 164,210 0.00 0.00
Market Capitalization		 89,224 64,258 80,160 78,703 72,988 76,562 53,715 103,829 0.00 0.00
Book Value per Share		 $24.44 $26.39 $25,222,525,718.48 $29,744,560,458.07 $0.00 $34.47 $33.94 $8,500,835,485.99 $4,034,916,346.92 $0.00
Tangible Book Value per Share		 ($23.61) ($23.17) ($18,785,118,542.15) ($22,829,959,582.35) $0.00 ($29.61) ($30.38) $2,078,191,639.62 ($1,940,527,478.02) $0.00
Total Capital		 108,864 118,082 143,890 144,530 118,687 145,131 144,211 277,701 34,426 0.00
Total Debt		 48,375 52,775 54,134 55,813 60,048 60,114 60,526 66,802 24,054 0.00
Total Long-Term Debt		 48,375 52,775 54,134 55,813 54,529 60,114 60,526 66,802 24,054 0.00
Net Debt		 38,536 43,412 46,687 48,708 52,721 54,139 54,998 60,081 21,335 0.00
Capital Expenditures (CapEx)		 -182 -69 -37 964 -60 -45 -48 1,193 -115 -159
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -5,011 -4,042 -2,546 -3,051 -1,904 -1,325 -3,824 -35,649 684 0.00
Debt-free Net Working Capital (DFNWC)		 2,447 2,811 2,461 1,424 2,970 2,185 -510 -31,058 3,403 0.00
Net Working Capital (NWC)		 2,447 2,811 2,461 1,424 -2,548 2,185 -510 -31,058 3,403 0.00
Net Nonoperating Expense (NNE)		 -903 4,031 1,063 1,100 1,334 8,832 19,469 -39,823 -1,520 -1,477
Net Nonoperating Obligations (NNO)		 38,522 43,394 40,044 48,690 80,884 53,756 54,715 -104,383 9,509 0.00
Total Depreciation and Amortization (D&A)		 3,883 36,463 1,576 1,453 1,980 0.00 1,322 1,219 749 631
Debt-free, Cash-free Net Working Capital to Revenue		 -15.47% -11.63% -7.62% -8.80% -5.41% -3.64% -7.72% -134.89% 3.92% 0.00%
Debt-free Net Working Capital to Revenue		 7.55% 8.09% 7.37% 4.11% 8.44% 6.00% -1.03% -117.52% 19.52% 0.00%
Net Working Capital to Revenue		 7.55% 8.09% 7.37% 4.11% -7.24% 6.00% -1.03% -117.52% 19.52% 0.00%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 2.00 -6.00 3.00 0.00 0.00 2.00 3.00 1.84K 0.00 0.00
Adjusted Diluted Earnings per Share		 $1.70 ($6.47) $2.92 $0.00 $0.00 $2.49 $2.63 $1,830.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 2.35B 2.46B 2.46B 0.00 0.00 2,456.52T 2.46B 2.46B 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 2.35B 2.46B 2.46B 0.00 0.00 2,456.52T 2.46B 2.46B 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 3,080 -14,050 9,331 10,515 10,298 10,313 27,153 6,063 4,450 5,187
Normalized NOPAT Margin		 9.51% -40.41% 27.94% 30.33% 29.25% 28.32% 54.83% 22.94% 25.53% 26.86%
Pre Tax Income Margin		 13.68% -62.53% 33.72% 35.68% 33.64% 28.79% 64.58% 150.93% 44.20% 44.68%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 4.22 -8.00 6.68 7.17 5.97 0.00 0.00 27.99 10.80 0.00
NOPAT to Interest Expense		 2.24 -5.82 4.71 5.24 4.32 0.00 0.00 7.47 5.66 0.00
EBIT Less CapEx to Interest Expense		 4.35 -7.97 6.70 6.69 5.99 0.00 0.00 27.18 10.95 0.00
NOPAT Less CapEx to Interest Expense		 2.37 -5.79 4.73 4.76 4.35 0.00 0.00 6.67 5.81 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 163.88% -35.63% 71.79% 72.47% 72.29% 0.00% -72.07% 9.65% 60.14% 61.26%
Augmented Payout Ratio		 163.88% -35.63% 71.79% 72.47% 72.29% 0.00% -72.07% 9.65% 60.14% 61.26%

Quarterly Metrics And Ratios for British American Tobacco

No quarterly metrics and ratios for British American Tobacco are available.

Frequently Asked Questions About British American Tobacco's Financials

When does British American Tobacco's financial year end?

According to the most recent income statement we have on file, British American Tobacco's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has British American Tobacco's net income changed over the last 9 years?

British American Tobacco's net income appears to be on a downward trend, with a most recent value of $3.98 billion in 2024, falling from $6.66 billion in 2015. The previous period was -$18.08 billion in 2023.

What is British American Tobacco's operating income?
British American Tobacco's total operating income in 2024 was $3.43 billion, based on the following breakdown:
  • Total Gross Profit: $26.83 billion
  • Total Operating Expenses: $23.41 billion
How has British American Tobacco revenue changed over the last 9 years?

Over the last 9 years, British American Tobacco's total revenue changed from $19.31 billion in 2015 to $32.39 billion in 2024, a change of 67.7%.

How much debt does British American Tobacco have?

British American Tobacco's total liabilities were at $88.38 billion at the end of 2024, a 2.8% increase from 2023, and a 128.4% increase since 2016.

How much cash does British American Tobacco have?

In the past 8 years, British American Tobacco's cash and equivalents has ranged from $2.72 billion in 2016 to $6.63 billion in 2024, and is currently $6.63 billion as of their latest financial filing in 2024.

How has British American Tobacco's book value per share changed over the last 9 years?

Over the last 9 years, British American Tobacco's book value per share changed from 0.00 in 2015 to 24.44 in 2024, a change of 2,444.1%.


Related Companies

This page (OTCMKTS:BTAFF) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...
Brownstone Research | Sponsored
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...
Behind the Markets | Sponsored
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
After Monday, price goes up 600% (hurry)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...
Timothy Sykes | Sponsored
Memorial Day Sale! 82% Off Disruptors and Dominators!
Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...
Weiss Ratings | Sponsored